×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
LS30: Paradigm Shift of Clinical Trial Site Costs ~Effort to Address the Diversifying Changes in Clinical Trial Design~
Session Chair(s)
Kenji Udo
Group Lead of Clinical Operations
Pfizer R&D Japan G.K., Japan
Speaker(s)
Toshiyuki Okada
Astellas Pharma Inc., Japan
Business Lead, Clinical Operational Excellence
Keiichi Inaizumi, MSc
Pfizer R&D Japan, Japan
Clinical Project Management Group/ Clinical Study Innovation Lead
Have an account?